Mycosis fungoides pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
<gallery widths=200px>
<gallery widths=200px>
Image:Sezary syndrome 0001.jpg| Sézary's disease
Image:Sezary syndrome 0001.jpg| Sézary's disease
Image:Cutaneous T-cell lymphoma - very high mag.jpg | [[Micrograph]] showing cutaneous T-cell lymphoma. [[H&E stain]].
Image:Cutaneous T-cell lymphoma - very high mag.jpg| [[Micrograph]] showing cutaneous T-cell lymphoma. [[H&E stain]].
</gallery>
</gallery>



Revision as of 14:31, 21 January 2016

Cutaneous T cell lymphoma Microchapters

Home

Patient Information

Overview

Classification

Mycosis fungoides
Sezary syndrome

Pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]

Overview

Pathophysiology

  • Cutaneous T cell lymphoma is an unusual expression of T-cells, a part of the immune system
  • These T-cells are skin-associated, meaning that they biochemically and biologically are most related to the skin, in a dynamic manner
  • Sezary syndrome and Mycosis Fungoides are T-cell lymphomas whose primary manifestation is in the skin
  • Mycosis Fungoides is the most common type of 'Cutaneous T cell lymphoma' (CTCL)
  • Mycosis fungoides is initially an indolent lymphoma but in its later stages can cause peripheral lymphadenopathy and can finally progress to widespread extracutaneous visceral / internal organ involvement
  • "Sézary's cells" are T-cells that have pathological quantities of mucopolysaccharides
  • Sézary's disease is sometimes considered a late stage of mycosis fungoides

Microscopic Pathology

References


Template:WikiDoc Sources